Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors - PubMed (original) (raw)

Short-term tumor control and acute toxicity after stereotactic radiosurgery for glomus jugulare tumors

Sheri A Poznanovic et al. Otolaryngol Head Neck Surg. 2006 Mar.

Abstract

Objective: Glomus jugulare tumors (GJT) have traditionally been treated by surgery or fractionated external beam radiation therapy (XRT). This study evaluates acute toxicity and short-term efficacy of single-fraction stereotactic radiosurgery (SRS) for the treatment of GJT.

Study design and setting: Eight patients (age range 28-74) with GJT underwent SRS (Brainlab linear accelerator) as primary treatment. A nominal dose of 15-16 Gy was prescribed.

Results: After undergoing SRS, 7 of 8 patients (87.5%) reported complete resolution of presenting symptoms. Follow-up MRIs showed tumor stabilization in 100% of patients. Transient vertigo occurred in one patient. One patient suffered acute GI upset and transient lower cranial neuropathy.

Conclusion: Stereotactic radiosurgery is an effective alternative for patients with GJT in achieving tumor control and resolution of symptoms.

Ebm rating: C-4.

PubMed Disclaimer

Similar articles

Cited by

MeSH terms

LinkOut - more resources